nice call you made a mini fortune what is your target on this
test efficacy shows no meaningful improvement. in fact a bit of toxicity concern. i expect phase 3 trial to fail and for the stock to be around 1 to 2 a share . kovner will offer support but not untill 1 or 2 a share
Excellent insight, thank you so very much. You are a talented individual with massive potential.
Keep up the hard work!!!